Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 7/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22600945 | 0.94 | PDK2 (0.33) | P2RX4MAPTSMN1; SMN2NPSR1PDK2 | |
| SCHEMBL3790816 | 0.94 | P2RX4 (0.35) | P2RX4MAPTSMN1; SMN2NPSR1MEN1 | |
| SCHEMBL14073373 | 0.91 | P2RX4 (0.33) | P2RX4MAPTSMN1; SMN2NPSR1MEN1 | |
| SCHEMBL22600910 | 0.91 | PGR (0.37) | MAPTSMN1; SMN2PDK2MEN1NPC1 | |
| SCHEMBL24062410 | 0.90 | PGR (0.38) | P2RX4MAPTSMN1; SMN2PDK2MEN1 | |
| SCHEMBL18544764 | 0.88 | PGR (0.35) | PDK2MEN1KMT2A | |
| SCHEMBL2604409 | 0.87 | PDK2 (0.37) | NPSR1PDK2MEN1KMT2A | |
| SCHEMBL12934421 | 0.87 | PGR (0.33) | P2RX4PDK2 | |
| SCHEMBL2604406 | 0.85 | PDK2 (0.35) | PDK2MEN1KMT2A | |
| SCHEMBL12793965 | 0.85 | PDK2 (0.35) | PDK2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2439803-B1 | PHOTOELECTRIC CONVERSION ELEMENT AND METHOD FOR PRODUCING SAME, PHOTOSENSOR, IMAGING ELEMENT AND METHOD OF DRIVING SAME | FUJIFILM CORP (JP) | 2017-11-08 | — | — | EP | disclosed |
| US-8847141-B2 | Photoelectric conversion element, production method thereof, photosensor, imaging device and their driving method | FUJIFILM CORPORATION (JP) | 2014-09-30 | — | — | US | disclosed |
| US-8847141-B2 | Photoelectric conversion element, production method thereof, photosensor, imaging device and their driving method | FUJIFILM CORPORATION (JP) | 2014-09-30 | — | — | US | disclosed |
| US-20120080585-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVING METHOD | FUJIFILM CORPORATION (JP) | 2012-04-05 | — | — | US | disclosed |
| US-20120080585-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVING METHOD | FUJIFILM CORPORATION (JP) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120080585-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVING METHOD | SUN2, CYBA, PPOX | P2RX4 1401/4885MAPT 342/4885SMN1; SMN2 4710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.